Literature DB >> 30202630

Active management of the third stage of labor: A brief overview of key issues.

Kemal Güngördük1, Yusuf Olgaç2, Varol Gülseren3, Mustafa Kocaer4.   

Abstract

Postpartum hemorrhage is a potentially life-threatening, albeit preventable, condition that persists as a leading cause of maternal death. It occurs mostly during the third stage of labor, and active management of the third stage of labor (AMTSL) can prevent its occurrence. AMTSL is a recommended series of steps, including the provision of uterotonic drugs immediately upon fetal delivery, controlled cord traction, and massage of the uterine fundus, as developed by the World Health Organization. Here, we present current opinion and protocols for AMTSL.

Entities:  

Keywords:  Postpartum hemorrhage; active management of the third stage of labor; uterotonic agents

Year:  2018        PMID: 30202630      PMCID: PMC6127474          DOI: 10.4274/tjod.39049

Source DB:  PubMed          Journal:  Turk J Obstet Gynecol        ISSN: 2149-9330


  35 in total

Review 1.  The fibrinolytic system-more than fibrinolysis?

Authors:  Dominik F Draxler; Robert L Medcalf
Journal:  Transfus Med Rev       Date:  2014-12-18

2.  ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

3.  The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial.

Authors:  Mojgan Mirghafourvand; Sakineh Mohammad-Alizadeh; Fatemeh Abbasalizadeh; Mina Shirdel
Journal:  Aust N Z J Obstet Gynaecol       Date:  2015-02       Impact factor: 2.100

Review 4.  Prostaglandins for preventing postpartum haemorrhage.

Authors:  Özge Tunçalp; G Justus Hofmeyr; A Metin Gülmezoglu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 5.  Tranexamic acid--an old drug still going strong and making a revival.

Authors:  Lilian Tengborn; Margareta Blombäck; Erik Berntorp
Journal:  Thromb Res       Date:  2014-11-20       Impact factor: 3.944

Review 6.  Postpartum hemorrhage--update on problems of definitions and diagnosis.

Authors:  Werner H Rath
Journal:  Acta Obstet Gynecol Scand       Date:  2011-05       Impact factor: 3.636

7.  Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.

Authors:  Ming-ying Gai; Lian-fang Wu; Qi-feng Su; Karin Tatsumoto
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2004-02-10       Impact factor: 2.435

8.  Efficacy of tranexamic acid in reducing blood loss after cesarean section.

Authors:  Leila Sekhavat; Afsar Tabatabaii; Maryam Dalili; Tahminah Farajkhoda; Atefah Dehghani Tafti
Journal:  J Matern Fetal Neonatal Med       Date:  2009-01

9.  High-dose tranexamic acid reduces blood loss in postpartum haemorrhage.

Authors:  Anne-Sophie Ducloy-Bouthors; Brigitte Jude; Alain Duhamel; Françoise Broisin; Cyril Huissoud; Hawa Keita-Meyer; Laurent Mandelbrot; Nadia Tillouche; Sylvie Fontaine; Françoise Le Goueff; Sandrine Depret-Mosser; Benoit Vallet; Sophie Susen
Journal:  Crit Care       Date:  2011-04-15       Impact factor: 9.097

10.  Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial.

Authors:  Bernadette Li; Alec Miners; Haleema Shakur; Ian Roberts
Journal:  Lancet Glob Health       Date:  2018-02       Impact factor: 38.927

View more
  1 in total

1.  Midwives' experiences of reducing maternal morbidity and mortality from postpartum haemorrhage (PPH) in Eastern Nigeria.

Authors:  Felicity Agwu Kalu; Joan N Chukwurah
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-08       Impact factor: 3.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.